Annabel Lyle, EngD, is an experienced Rates Quantitative Developer at SilverTide since August 2025, having previously held the position of Quantitative Developer at TP ICAP from September 2023 to September 2025, focusing on quantitative analytics and development in derivatives. Prior to that, Annabel served as a Postgraduate Researcher at AstraZeneca from September 2019 to September 2023, working on bioprocess economics and biopharmaceutical portfolio management as part of the UCL Decisional Tools group. Annabel's career began with a role as an Investment Banking Summer Analyst at J.P. Morgan in the EMEA Healthcare Investment Banking Team in 2018. Academic achievements include a Doctor of Engineering (EngD) in Biochemical Engineering from UCL (2019-2023) and a Bachelor's degree in the same field from UCL (2016-2019), following A Levels at Gowerton Comprehensive School (2009-2016).
This person is not in the org chart
This person is not in any teams
This person is not in any offices